4 research outputs found
Supplementary Figure 2 from Quantitative Chemical Proteomics Profiling Differentiates Erlotinib from Gefitinib in <i>EGFR</i> Wild-Type Non–Small Cell Lung Carcinoma Cell Lines
No full textXLSX file - 24K, Statistics of proteins that significantly decrease in their relative abundance with increasing compound concentration, in at least one of the two compounds</p
Supplementary Table 1 from Quantitative Chemical Proteomics Profiling Differentiates Erlotinib from Gefitinib in <i>EGFR</i> Wild-Type Non–Small Cell Lung Carcinoma Cell Lines
No full textXLSX file - 144K, Protein identifications in eluted fractions from erlotinib-Sepharose and gefitinib-Sepharose</p
Supplementary Figure 1 from Quantitative Chemical Proteomics Profiling Differentiates Erlotinib from Gefitinib in <i>EGFR</i> Wild-Type Non–Small Cell Lung Carcinoma Cell Lines
No full textPDF file - 60K, Schematic diagram of the experimental framework applied to perform label-free, quantitative chemical proteomics on erlotinib and gefitinib</p
